Immunome IMNM
NASDAQ IMNM
$19.36 +0.65 (+3.47%)
At close: Nov 9, 2026 · 4:00 PM EST

Immunome (IMNM) Current Deferred Revenue (2023 - 2025)

Updated

Immunome (IMNM) reported Current Deferred Revenue of $4.02 million for Q1 2025, down 68.5% from $12.75 million a year earlier and down 42.2% from the prior quarter.

Analysis

Immunome (IMNM) Current Deferred Revenue (2023 - 2025) Analysis & Trends

At the end of FY2024, Immunome posted Current Deferred Revenue of $6.94 million, down 33.9% from FY2023.

  • By year, Current Deferred Revenue came in at $10.49 million in FY2023.
  • The Q1 2025 figure ranks as the lowest quarterly Current Deferred Revenue in data going back to Q1 2023.
  • Year over year, Current Deferred Revenue has now declined in each of the last five quarters, with an average decline of 40.8% over the last five quarters.
  • Per Business Quant data, the three quarters before Q1 2025 came in at $6.94 million (Q4 2024), $9.68 million (Q3 2024) and $12.59 million (Q2 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn
10 Immunome 2.20 Bn 169.23 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 4.02 Mn
Dec 31, 2024 6.94 Mn
Sep 30, 2024 9.68 Mn
Jun 30, 2024 12.59 Mn
Mar 31, 2024 12.75 Mn
Dec 31, 2023 10.49 Mn
Sep 30, 2023 16.96 Mn
Jun 30, 2023 17.67 Mn
Mar 31, 2023 18.22 Mn
API Access

Immunome Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=IMNM&period=max&api_key=YOUR_API_KEY